LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
BT-20 PD0325901
10.0
uM
LJP5
 0.5707 0.0452 0.3803 0.0543
BT-20 PD0325901
10.0
uM
LJP6
 0.5787 0.0034 0.3896 0.0086
BT-20 PD173074
10.0
uM
LJP6
 0.8691 0.0742 0.8072 0.1118
BT-20 PD184352
10.0
uM
LJP5
 0.4830 0.0505 0.2480 0.0891
BT-20 Pelitinib
10.0
uM
LJP5
 0.1939 0.0225 -0.1695 0.0563
BT-20 PF431396
10.0
uM
LJP5
 0.2202 0.0484 -0.1319 0.0875
BT-20 PF477736
10.0
uM
LJP5
 0.3837 0.0376 0.1047 0.0722
BT-20 PF562271
10.0
uM
LJP6
 0.2089 0.0148 -0.1464 0.0305
BT-20 PHA-665752
10.0
uM
LJP5
 0.4582 0.1527 0.2157 0.2164
BT-20 PHA-793887
10.0
uM
LJP6
 0.2063 0.0222 -0.1510 0.0498
BT-20 PI103
10.0
uM
LJP6
 0.2526 0.0085 -0.0828 0.0158
BT-20 PLX-4720
10.0
uM
LJP5
 0.5585 0.0305 0.3620 0.0325
BT-20 QL-X-138
10.0
uM
LJP6
 0.2044 0.0132 -0.1527 0.0228
BT-20 QL-XII-47
10.0
uM
LJP6
 0.1893 0.0220 -0.1746 0.0329
BT-20 Radicicol
10.0
uM
LJP5
 0.2347 0.0255 -0.1086 0.0347
BT-20 Radicicol
10.0
uM
LJP6
 0.2276 0.0358 -0.1185 0.0448
BT-20 Seliciclib
10.0
uM
LJP5
 0.4220 0.0126 0.1625 0.0204
BT-20 Ruxolitinib
10.0
uM
LJP5
 0.7764 0.0323 0.6754 0.0482
BT-20 XL147
10.0
uM
LJP5
 0.3939 0.0156 0.1207 0.0403
BT-20 Saracatinib
10.0
uM
LJP6
 0.4553 0.0344 0.2122 0.0381
BT-20 Selumetinib
10.0
uM
LJP6
 0.9581 0.0419 0.9412 0.0594
BT-20 Sirolimus
10.0
uM
LJP6
 0.6673 0.0239 0.5187 0.0283
BT-20 Sorafenib
10.0
uM
LJP6
 0.5699 0.1448 0.3850 0.2002
BT-20 SU11274
10.0
uM
LJP5
 0.3456 0.0175 0.0512 0.0378
BT-20 Fedratinib
10.0
uM
LJP5
 0.2406 0.0344 -0.1010 0.0588